Table 1

Health utility estimates from EQ-5D-5L data collected during the ORBITA trial; higher scores indicate better health

Utility weight
Health stateNumberMeanSESD
CAD (baseline)1950.770.0150.213
Placebo910.810.0210.221
PCI1040.830.0230.212
  • Number =the number of patients in the sample, with a complete EQ-5D utility weight, used to estimate the mean, SE and SD.

  • CAD, coronary artery disease; ; EQ-5D-5L, EuroQol five-dimension quality of life instrument, 5-level version; ORBITA trial, Objective Randomised Blinded Investigation with optimal medical Therapy of Angioplasty in stable angina trial; PCI, percutaneous coronary intervention; SD, Standard deviation; SE, Standard error.